SEARCH

SEARCH BY CITATION

Keywords:

  • age;
  • β-cell function;
  • coronary artery disease;
  • oestrone;
  • smoking;
  • whole blood viscosity;
  • women

Abstract.  Os I, Høieggen A, Larsen A, Sandset PM, Djurovic S, Berg K, Os A, Birkeland K, Westheim A (University of Oslo; Ulleval University Hospital; and Aker University Hospital, Oslo, Norway). Smoking and relation to other risk factors in postmenopausal women with coronary artery disease, with particular reference to whole blood viscosity and β-cell function. J Intern Med 2003; 253: 232–239.

Objectives.  To investigate possible associations between smoking habits and other coronary risk factors in postmenopausal women with known coronary heart disease (CHD).

Setting.  The study was conducted at a university clinic.

Subjects.  A total of 118 postmenopausal women with CHD verified with angiography, consecutively recruited.

Interventions.  Conventional treatment for CHD. The women were randomized to hormone replacement therapy (HRT) with transdermal 17-β oestradiol and medroxyprogesterone acetate, or to a control group.

Results.  Smokers were younger (P = 0.005), had lower body mass index (P = 0.04) and lipoprotein Lp(a) levels (P = 0.02) compared with nonsmokers. Smokers had reduced β-cell function (homeostasis model assessment, P = 0.006), whereas whole blood viscosity (WBV) was higher at all shear rates. WBV was not affected by HRT over a 12-month period. Oestrone levels were higher in smokers.

Conclusions.  Smoking adversely affects insulin secretion (β-cell function) and WBV in postmenopausal women with established CHD, which could be of importance as a mechanism for the increased risk of CHD in smokers. The importance of smoking as a risk factor, overrides the effect of Lp(a), which is lower in smokers compared with nonsmokers.